Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca sagas illustrate strength of COVID-19 strategy: ‘It was a wise decision to spread the risk’
‘Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’
